Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial.
Saved in:
| Title: | Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial. |
|---|---|
| Authors: | Burton JO; Division of Cardiovascular Sciences, University of Leicester and University Hospitals of Leicester, Leicester, UK., Izquierdo MJ; Head of Nephrology Department, University Hospital of Burgos, Burgos, Spain., Linde C; Department of Cardiology, Karolinska Institutet, Stockholm, Sweden., Robles NR; Universidad de Extremadura, Head Nephrology Department and Hypertension Unit, Hospital Universitario de Badajoz, Badajoz, Spain., Sood MM; Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada., Allum AM; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Eudicone JM; BioPharmaceuticals Medical Evidence, AstraZeneca, Wilmington, DE, USA., Dahl M; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden., Amin AN; Department of Medicine, University of California Irvine, Irvine, CA, USA. |
| Source: | Clinical kidney journal [Clin Kidney J] 2026 May 19; Vol. 19 (6), pp. sfag158. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101579321 Publication Model: eCollection Cited Medium: Print ISSN: 2048-8505 (Print) Linking ISSN: 20488505 NLM ISO Abbreviation: Clin Kidney J Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2048-8505 |
|---|---|
| DOI: | 10.1093/ckj/sfag158 |
